Saturday, 21 December 2019

U.S. FDA declines to approve GSK drugs division's long acting HIV injection

GlaxoSmithKline's HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.


from Reuters: Health News https://ift.tt/35LokMQ

No comments:

Post a Comment